Showing results (241-250 of 249) with videos related to
Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 249 results.
World Journal of Clinical Cases|October 17, 2022
One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or CJing-Hang Xu, Sa Wang, Da-Zhi Zhang, et al.Cancer Research|January 27, 2026
Targeting LRRC15 in Cancer-Associated Fibroblasts Modifies the Extracellular Matrix and Enhances Tumor Immune Responses to Suppress Lung Cancer ProgressionLu Qi, Guohui Dang, Xinnan Ling, et al.Plant Physiology and Biochemistry : PPB|January 19, 2023
Foxtail millet MYB-like transcription factor SiMYB16 confers salt tolerance in transgenic rice by regulating phenylpropane pathwayYue Yu, Dong-Dong Guo, Dong-Hong Min, et al.EMBO Molecular Medicine|February 1, 2020
Inhibiting MARSs reduces hyperhomocysteinemia-associated neural tube and congenital heart defectsXinyu Mei, Dashi Qi, Ting Zhang, et al.Ebiomedicine|September 26, 2021
Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndromeYang Yuan, Qing-Bin Lu, Wen-Si Yao, et al.Journal of Viral Hepatitis|June 23, 2022
240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or CJing-Hang Xu, Ya-Nan Fan, Yan-Yan Yu, et al.Food Microbiology|July 9, 2026
Comparative genomics and phenotypes of Listeria monocytogenes isolated from enoki mushrooms in South Korea and ChinaWen Si Hu, So Hyeon An, Dong Woo Kim, et al.World Journal of Clinical Cases|July 5, 2021
Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeksXiao-Fan Chen, Ya-Nan Fan, Chong-Wen Si, et al.Medicine|August 16, 2019
A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48Rong-Yue Liang, Jing-Hang Xu, Chong-Wen Si, et al.Pageof 25